Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Consumer Resources

Policy TrackerSenate Bills Search Results « » The Henry J. Kaiser Family Foundation

Senate Bills

  • your selections
Clear Search

Filter Results

date

Area

Information Type

Organization/Initiative

Issue/Condition

  • results
Senate Appropriations Committee releases legislation providing funding for remainder of FY13

The Senate Committee on Appropriations released proposed legislation to provide funding for the remainder of the 2013 Fiscal Year. The proposed legislation would provide funding for global health programs at the State Department and United States Agency for International Development (USAID) under a Continuing Resolution (CR). The proposed resolution calls for…

Bill introduced to provide incentives for the development of qualified infectious disease products

Senator Richard Blumenthal (D-CT) introduced S. 1734 – Generating Antibiotic Incentives Now Act of 2011.  The bill provides incentives for the development of “antibiotic drug[s] for treating, detecting, preventing, or identifying a qualifying pathogen,” including, among other infectious agents, multi-drug resistant tuberculosis.

Learn more about the House companion bill (H.R. 2182).

Senate Appropriations Committee introduces Continuing Resolution for the remainder of FY 2011; includes overall increase in global health funding

The Senate Committee on Appropriations introduced a Continuing Resolution (CR) that would authorize appropriations for the remaining seven months of FY 2011 (the first 5 months of FY 2011 were funded under FY 2010 levels). This legislation would replace the full-year appropriations bill (H.R. 1) that was recently passed by the House on February 19, 2011. Unlike H.R. 1, which proposes to cut global health funding, the Senate CR proposes an overall increase in global health funding (see table below). Additionally, the summary of the CR provided by the Senate Committee on Appropriations categorizes State and Foreign Operations funding as part of National Security.

S. 606 – Creating Hope Act of 2011

The proposed bill would amend the Food and Drug Administration (FDA) Amendments Act of 2007, which, among other things, established a “priority review voucher” entitling pharmaceutical companies that developed a treatment for tropical diseases to an expedited review of another drug by that company or sale of the voucher to another company. The proposed bill would allow for repeated transferability (or sale) of the priority review vouchers, expand voucher eligibility to include drug development for rare pediatric diseases, and add “Chagas Disease” to the classification of tropical diseases.